Uxolo Pharma Llp - Due diligence report

A 360° intelligence report on Uxolo Pharma Llp: trust score, financial health, credit view, compliance, directors, growth and distress signa…

2020-12-03 Chennai, Tamil Nadu Active
Connect MCP
UP Uxolo Pharma Llp
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Uxolo Pharma Llp — 360° Intelligence Report

Generated from MCA filings & public records
88/100
Trust Score
Low Risk

Uxolo Pharma Llp is assessed as Low Risk with a Trust Score of 88/100. Uxolo Pharma Llp is an active limited liability partnership incorporated in 2020, operating in the Pharma sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a low compliance risk and an unassessed financial risk profile.

Report generated on 13 Oct 2026 from the latest processed filings. Uxolo Pharma Llp snapshot & full profile →

Overall Assessment CautionWeakNeutralGoodStrong Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
88/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
90/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreNo Data
N/A
No processed financial statements available yet.
Credit Risk ScoreNo Data
N/A
Financial statements needed for a credit view.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

No processed financials
Financial statements are not yet processed for this company. Trend analysis will appear once filings are available.
04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: N/A No Data
  • Financial statements needed for a credit view.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 90/100 Low Risk
  • Company status is Active as per MCA.
  • No balance-sheet filing date on record.
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
KUNHI PARAMBATH LUBAID 01234567 Director 01/04/2018 6 yrs Approved
SAMEER KUNHI PARAMBIL 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth N/A · Distress 90
Growth signals & trust indicators
Operating for 5 years.
Financials unavailable - score leans on compliance and governance signals.
Distress signals & risk flags
No critical warning flags detected in the available data.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence89/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • No financials on record - ask for audited statements.
Banker assessment77/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • No filed financials - rely on banking statements and GST data.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view68/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Request management accounts - public filings insufficient.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 3 events
03 Dec 2020
Incorporated
Registered with Roc Chennai
Director appointed
KUNHI PARAMBATH LUBAID (Designated Partner)
Director appointed
SAMEER KUNHI PARAMBIL (Designated Partner)
10

Key Observations

Auto-generated from the data above
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Steepleware Solutions Private Limited U72200TN2005PTC055387 Chennai, Tamil Nadu
Struct House India Private Limited U45309TN2019PTC131756 Chennai, Tamil Nadu
Cranecare Private Limited U52602TN2021PTC142823 Chennai, Tamil Nadu
Dynamic Leather Wholesaler Private Limited U51909TN2021PTC147410 Chennai, Tamil Nadu
Skywalkers Infotech Private Limited U72200TN2007PTC062478 Chennai, Tamil Nadu
Arkitin Private Limited U72900TN2022PTC155597 Chennai, Tamil Nadu
One-Man Services (Opc) Private Limited U52100TN2022OPC149926 Chennai, Tamil Nadu
Lightbeam Projects Private Limited U74999TN2018PTC122581 Chennai, Tamil Nadu
Focuzcloud Technology Private Limited U72900TN2012PTC085896 Chennai, Tamil Nadu
VENKATARAMANA MINERALS LLP AAX-1570 Chennai, Tamil Nadu
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Uxolo Pharma Llp before audits and certifications: compliance score 90/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Uxolo Pharma Llp: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score pending financials, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score n/a, margin trends, ownership structure and peer set for Uxolo Pharma Llp - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 88/100, distress signals and MSME payment-delay disclosures - know whether Uxolo Pharma Llp pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Uxolo Pharma Llp - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Uxolo Pharma Llp an active company?

Uxolo Pharma Llp has MCA status “Active” with a compliance score of 90/100 (Low Risk).

Is Uxolo Pharma Llp financially healthy?

Processed financial statements are not yet available for Uxolo Pharma Llp, so its financial health is unassessed.

Should I do business with Uxolo Pharma Llp?

Its overall Trust Score is 88/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Uxolo Pharma Llp?

See the directors and ownership sections above for board and shareholding detail. 2 active director(s) are on record.

Does Uxolo Pharma Llp have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Uxolo Pharma Llp up to date with its ROC filings?

No balance-sheet filing date on record. Overall compliance score: 90/100 (Low Risk).

Is it risky to lend to Uxolo Pharma Llp?

Filed financial statements are needed for a credit view - ask the company for audited statements and bank statements.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.